IHME in the news
Read what major media outlets are saying about our work.Dor nas costas, principal causa de incapacidade, já atinge 600 milhões de pessoas e deve aumentar; saiba os motivos
Esse aumento nos próximos anos se deve, segundo Garland Culbreth, pesquisadora do Institute for Health Metrics and Evaluation da Universidade de Washington e autora do estudo, "às tendências de crescimento e envelhecimento populacional".
Preventive tips to avoid asthma triggers during summer
According to the Global Burden of Disease (GBD) report, approximately 30 million asthmatics live in India, making up 13.09% of the worldwide burden.
La lumbalgia será la nueva pandemia para el año 2050 de acuerdo a una nueva investigación
La National Geographic explica que el estudio, llevado a cabo por el Instituto de Métricas y Evaluación de la Salud (IHME) de la Facultad de Medicina de la Universidad de Washington, muestra que las personas de edad avanzada son las que corren un mayor riesgo particular.
Over 800 million people globally may suffer back pain by 2050: Lancet study
The study analysed Global Burden of Disease (GBD) data from 1990 to 2020 from over 204 countries and territories to map the landscape of back pain cases over time.
Population explosion: Separating asset from liability
Researchers at the University of Washington’s Institute for Health Metrics and Evaluation also showed the global fertility rate nearly halved to 2.4 in 2017 – and their study projects it will fall below 1.7 by the turn of this century.
Factbox: How countries have legislated after mass shootings
Canada's rate of firearm homicides is 0.5 per 100,000 people versus a U.S. rate of 4.12, the University of Washington's Institute for Health Metrics and Evaluation (IHME) said in a 2021 analysis.
The silent threat: Women and heart disease in India
According to the Global Burden of Disease Study, heart disease is the leading cause of death among women in India, accounting for almost 18% of all female deaths.
What to know about XBB.1.16, the 'Arcturus' variant
Ali Mokdad, a professor of global health at the University of Washington, said it’s still too early to predict what XBB.1.16 will do. But what he’s seen so far has been reassuring. “We haven’t seen an increase in hospitalizations, we haven’t seen an increase in any of the indicators that make us worry,” Mokdad said.
The incredible challenge of counting every global birth and death
“I think eventually we’ll find out,” says Chris Murray, now the director of the Institute for Health Metrics and Evaluation at the University of Washington School of Medicine. “But it is remarkable how much uncertainty there is on a subject that’s actually quite important.”
La 'vacuna' contra el estrés de los estudiantes que nació en el Valle y se ha convertido en modelo nacional
En marzo del 2022, un informe de la Organización Mundial de la Salud, OMS, basado en una revisión de las repercusiones de la pandemia en la salud mental, y en estimaciones del último estudio de Global Burden of Disease, concluyó que la pandemia desencadenó un aumento del 26 % y un incremento del 28 % de la ansiedad y los trastornos depresivos graves en el mundo y que la población joven corre un riesgo desproporcionado de comportamientos suicidas y autolesivos.
Multidisciplinary, sustainable solutions to address the global burden of noncommunicable diseases
The Global Burden of Disease Study in 2019 noted that non-communicable diseases (NCDs) are responsible for 63% of deaths in India. Apart from the health impact, NCDs also lead to immense financial loss.
COVID-19 death rates varied dramatically across US, major analysis finds
"We can invest in programs that protect the communities that we see disproportionately affected by the pandemic," said co-lead author Emma Castro, a researcher at the Institute for Health Metrics and Evaluation at the University of Washington, in the video commentary.
The pandemic at 3
Researchers from the Institute for Health Metrics and Evaluation at the University of Washington have mapped out some scenarios that weigh vaccine uptake, fading protection and antiviral use, among other factors, to project what we can expect across the globe through the end of June.
What worked against COVID: Masks, closures and vaccines
Despite these limitations, three independent analyses of excess mortality—by the World Health Organization, the Institute for Health Metrics and Evaluation and the Economist—reach similar conclusions. In the first three years of the pandemic, more than 20 million excess deaths occurred globally.
The winter COVID wave that wasn't: Why the US didn't see a surge
"We did not see a wave because we had a very high immunity due to infections and vaccinations," Dr. Ali Mokdad, an epidemiologist with the University of Washington's Institute for Health Metrics and Evaluation in Seattle, told ABC News. "Omicron and its subvariants did not spare anyone. Also, many of the infections were minor and not reported or did not end in a hospitalization."